These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 30975306)
1. Oral Anticoagulation Therapy and Progression of Calcific Aortic Valve Stenosis. Tastet L; Pibarot P; Shen M; Clisson M; Côté N; Salaun E; Arsenault M; Bédard É; Capoulade R; Puri R; Poirier P; Clavel MA J Am Coll Cardiol; 2019 Apr; 73(14):1869-1871. PubMed ID: 30975306 [No Abstract] [Full Text] [Related]
2. Cardiac valve calcification and use of anticoagulants: Preliminary observation of a potentially modifiable risk factor. Di Lullo L; Tripepi G; Ronco C; D'Arrigo G; Barbera V; Russo D; Di Iorio BR; Uguccioni M; Paoletti E; Ravera M; Fusaro M; Bellasi A Int J Cardiol; 2019 Mar; 278():243-249. PubMed ID: 30538058 [TBL] [Abstract][Full Text] [Related]
3. Aortic valve stenosis and lipid-lowering therapy: the state of the art. Bonadei I; Vizzardi E; D'aloia A; Gelsomino S; De Cicco G; Lorusso R; Dei Cas L Panminerva Med; 2013 Dec; 55(4):391-5. PubMed ID: 24434347 [TBL] [Abstract][Full Text] [Related]
4. Bioprosthesis leaflet thrombosis following self-expanding valve-in-valve transcatheter aortic valve replacement in patient taking factor Xa inhibitor and warfarin: A case report. Buchanan KD; Alraies MC; Weissman G; Ben-Dor I; Satler LF; Waksman R Cardiovasc Revasc Med; 2018 Jan; 19(1 Pt A):29-32. PubMed ID: 29066342 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for progression of early- and late-stage calcific aortic valve disease in Japanese: the Japanese Aortic Stenosis Study (JASS) Retrospective Analysis. Yamamoto K; Yamamoto H; Yoshida K; Kisanuki A; Hirano Y; Ohte N; Akasaka T; Takeuchi M; Nakatani S; Ohtani T; Sozu T; Masuyama T Hypertens Res; 2010 Mar; 33(3):269-74. PubMed ID: 20057483 [TBL] [Abstract][Full Text] [Related]
6. Bone Mineral Density and Progression Rate of Calcific Aortic Valve Stenosis. Tastet L; Shen M; Capoulade R; Arsenault M; Bédard É; Côté N; Clavel MA; Pibarot P J Am Coll Cardiol; 2020 Apr; 75(14):1725-1726. PubMed ID: 32273038 [No Abstract] [Full Text] [Related]
7. Warfarin, but not rivaroxaban, promotes the calcification of the aortic valve in ApoE-/- mice. Rattazzi M; Faggin E; Bertacco E; Nardin C; Pagliani L; Plebani M; Cinetto F; Guidolin D; Puato M; Pauletto P Cardiovasc Ther; 2018 Aug; 36(4):e12438. PubMed ID: 29847020 [TBL] [Abstract][Full Text] [Related]
8. Dysfunction of a 21-mm aortic bioprosthesis treated with percutaneous implantation of a CoreValve prosthesis. Giannini C; De Carlo M; Guarracino F; Donne MG; Benedetti G; Verunelli F; Petronio AS J Cardiovasc Med (Hagerstown); 2013 Jul; 14(7):541-4. PubMed ID: 20407385 [TBL] [Abstract][Full Text] [Related]
9. Heartbeat: is medical therapy for calcific aortic stenosis possible? Otto CM Heart; 2020 Dec; 106(23):1783-1785. PubMed ID: 33188040 [No Abstract] [Full Text] [Related]
11. Natural history of mild and of moderate aortic stenosis-new insights from a large prospective European study. Gohlke-Bärwolf C; Minners J; Jander N; Gerdts E; Wachtell K; Ray S; Pedersen TR Curr Probl Cardiol; 2013 Sep; 38(9):365-409. PubMed ID: 23972937 [TBL] [Abstract][Full Text] [Related]
12. Correlation between calcific aortic stenosis diagnosed by two-dimensional echocardiography and cardiac catheterization. Nair CK; Aronow WS; Sketch MH; Mohiuddin SM; Stokke K; Ryschon K Clin Cardiol; 1984 May; 7(5):280-2. PubMed ID: 6713747 [TBL] [Abstract][Full Text] [Related]
13. Targeted therapy to prevent progression of calcific aortic stenosis. Rajamannan NM; Otto CM Circulation; 2004 Sep; 110(10):1180-2. PubMed ID: 15353511 [No Abstract] [Full Text] [Related]
14. Dipeptidyl peptidase-4 inhibition to prevent progression of calcific aortic stenosis. Lee S; Lee SA; Choi B; Kim YJ; Oh SJ; Choi HM; Kim EK; Kim DH; Cho GY; Song JM; Park SW; Kang DH; Song JK Heart; 2020 Dec; 106(23):1824-1831. PubMed ID: 32917732 [TBL] [Abstract][Full Text] [Related]
15. Impact of Aortic Valve Calcification and Sex on Hemodynamic Progression and Clinical Outcomes in AS. Tastet L; Enriquez-Sarano M; Capoulade R; Malouf J; Araoz PA; Shen M; Michelena HI; Larose É; Arsenault M; Bédard É; Pibarot P; Clavel MA J Am Coll Cardiol; 2017 Apr; 69(16):2096-2098. PubMed ID: 28427584 [No Abstract] [Full Text] [Related]
16. Aortic valve stenosis as a cause of major systemic embolism--a case report. Kaul H; Gutzwiller JP; Schneider K; Dirsch O; Häusermann M Angiology; 1998 Mar; 49(3):231-4. PubMed ID: 9523547 [TBL] [Abstract][Full Text] [Related]
17. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. Cowell SJ; Newby DE; Prescott RJ; Bloomfield P; Reid J; Northridge DB; Boon NA; N Engl J Med; 2005 Jun; 352(23):2389-97. PubMed ID: 15944423 [TBL] [Abstract][Full Text] [Related]
18. The effect of statins on valve function and calcification in aortic stenosis: A meta-analysis. Zhao Y; Nicoll R; He YH; Henein MY Atherosclerosis; 2016 Mar; 246():318-24. PubMed ID: 26828749 [TBL] [Abstract][Full Text] [Related]
19. Relation of circulating Matrix Gla-Protein and anticoagulation status in patients with aortic valve calcification. Koos R; Krueger T; Westenfeld R; Kühl HP; Brandenburg V; Mahnken AH; Stanzel S; Vermeer C; Cranenburg EC; Floege J; Kelm M; Schurgers LJ Thromb Haemost; 2009 Apr; 101(4):706-13. PubMed ID: 19350115 [TBL] [Abstract][Full Text] [Related]
20. Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: Results from the ASTRONOMER trial. Capoulade R; Chan KL; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S Atherosclerosis; 2017 May; 260():1-7. PubMed ID: 28319871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]